Capricor Therapeutics (CAPR) Interest Coverage Ratio Growth (1y) (2014 - 2017)
Capricor Therapeutics (CAPR) Interest Coverage Ratio Growth (1y) (2014 - 2017) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
-303.06% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
18.06% |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
67.94% |
| 10 |
Capricor Therapeutics |
1.53 Bn |
1.26 Bn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2017 |
-44.29% |
| Sep 30, 2017 |
53.83% |
| Jun 30, 2017 |
46.63% |
| Mar 31, 2017 |
46.83% |
| Dec 31, 2016 |
45.20% |
| Sep 30, 2016 |
-14.82% |
| Jun 30, 2016 |
-20.86% |
| Mar 31, 2016 |
-15.02% |
| Dec 31, 2015 |
-67.14% |
| Sep 30, 2015 |
-87.00% |
| Jun 30, 2015 |
-83.41% |
| Mar 31, 2015 |
-18.28% |
| Dec 31, 2014 |
67.46% |
| Sep 30, 2014 |
61.37% |
| Jun 30, 2014 |
89.59% |
| Mar 31, 2014 |
87.87% |
